Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis

American Journal of Tropical Medicine and Hygiene

Volumn 69, Issue 6, 2003, Pages 621-623

  Kipp, Walter ^a   Bamhuhiiga, Jotham ^b   Rubaale, Tom ^b   Büttner, Dietrich W ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Bernhard Nocht Inst for Trop Med ^*  (Uganda)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; ANTIFILARIAL AGENT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CHILD; CHILL; CLINICAL EXAMINATION; DIZZINESS; DRUG SAFETY; DYSPNEA; EDEMA; EYE DISEASE; FEMALE; FEVER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; ORTHOSTATIC HYPOTENSION; PAIN; PHOTOPHOBIA; PROFESSIONAL PRACTICE; SIMULIUM; SIMULIUM NEAVEI; SINGLE DRUG DOSE; SKIN MANIFESTATION; UGANDA; VISUAL IMPAIRMENT; ANIMAL; DISEASE CARRIER; DRUG ADMINISTRATION; DRUG ERUPTION; DRUG SURVEILLANCE PROGRAM; FLY; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; PREVALENCE;

ONCHOCERCA; ONCHOCERCA VOLVULUS; SIMULIUM NEAVEI;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANIMALS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG ERUPTIONS; FEMALE; FILARICIDES; HUMANS; INSECT VECTORS; IVERMECTIN; MALE; MIDDLE AGED; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PREVALENCE; SIMULIIDAE; UGANDA;

EID: 1342289663     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.69.621     Document Type: Article

References (14)

1. Lindley D, 1987. Merck's new drug free to WHO for river blindness program. Nature 329: 752.
2. Goa K, McTavish D, Clissold S, 1991. Ivermectin. A review of its antimicrofilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs 42: 640-658.
3. Remme J, Baker RHA, De Sole G, Dadzie KY, Walsh JF, Adams MA, Alley ES, Avissey HSK, 1989. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus. Trop Med Parasitol 40: 367-374.
4. Whitworth J, Morgan D, Maude G, Downham M, Taylor D, 1991. A community trial of ivermectin for onchocerciasis in Sierra Leone: adverse reactions after the first five treatment rounds. Trans R Soc Trop Med Hyg 85: 501-505.
5. Pacque M, Munoz B, Green BM, Taylor HR, 1991. Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment. J Infect Dis 163: 381-385.
6. De Sole G, Remme J, Awadzi K, Accorsi S, Alley E, Ba O, Dadzie K, Giese J, Karam M, Keita F, 1989. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull World Health Organ 67: 707-719.
7. Ogunba E, Gemade E, 1992. Preliminary observations on the distribution of ivermectin in Nigeria for control of river blindness. Ann Trop Med Parasitol 86: 649-655.
8. Fischer P, Kipp W, Bamuhiiga J, Binta-Kahwa J, Kiefer A, Buttner DW, 1993. Parasitological and clinical characterization of Simulium neavei transmitted onchocerciasis in western Uganda. Trop Med Parasitol 44: 911-921.
9. Fischer P, Bamuhiiga J, Kilian A, Büttner DW, 1996. Strain differences of Onchocerca volvulus from Uganda using DNA probes. Parasitology 112: 401-408.
10. Fischer P, Kipp W, Kabwa P, Büttner D, 1995. Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin. Am J Trop Med Hyg 53: 171-178.
11. Njoo FL, Beek WM, Keukens HJ, van Wilgenburg H, Oosting J, Stilma JS, Kijlstra A, 1995. Ivermectin detection in serum of onchocerciasis patients: relations to adverse reactions. Am J Trop Med Hyg 52: 94-97.
12. Mwetta E, Hills E, 1994. Community treatment with ivermectin for onchocerciasis in the east Usambara mountains. East Afr Med J 71: 790-791.
13. Burnham G, 1993. Adverse reactions to ivermectin treatment for onchocerciasis. Results of a placebo-controlled, double-blind trial in Malawi. Trans R Soc Trop Med Hyg 87: 313-317.
14. Kipp W, Burnham DG, Bamuhiiga J, Weis P, Buttner DW, 1998. Ivermectin distribution using community volunteers in Kabarole district, Uganda. Int J Health Policy Plann 13: 167-173.